SCHEMBL3936780

SCHEMBL3936780

CCOC(=O)C1c2ccccc2C(=O)N1Cc1ccccc1OC

nearest known ligand 0.61

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
THRB P10828 1/20 0.55
ALDH1A1 P00352 4/20 0.53
NPSR1 Q6W5P4 2/20 0.53
TSHR P16473 1/20 0.53
LMNA P02545 3/20 0.50
SMN1; SMN2 Q16637 2/20 0.50
F2 P00734 1/20 0.50
MAPT P10636 1/20 0.49
MEN1 O00255 1/20 0.49
KMT2A Q03164 1/20 0.49
TP53 P04637 1/20 0.47
KCNA5 P22460 3/20 0.47
KCNH2 Q12809 2/20 0.47
RECQL P46063 1/20 0.47
POLB P06746 1/20 0.47
MAPK1 P28482 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
HPGD P15428 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3932048 0.90 ALDH1A1 (0.52) THRBALDH1A1NPSR1TSHRLMNA
SCHEMBL3932445 0.86 ALDH1A1 (0.56) THRBALDH1A1NPSR1TSHRLMNA
SCHEMBL1888404 0.81 FFAR1 (0.50) THRBALDH1A1TSHRMAPTPOLB
SCHEMBL4008342 0.80 ALDH1A1 (0.56) THRBALDH1A1NPSR1TSHRLMNA
SCHEMBL3754130 0.80 KCNA5 (0.73) THRBALDH1A1NPSR1TSHRLMNA
SCHEMBL3934300 0.80 ALDH1A1 (0.54) THRBALDH1A1NPSR1TSHRLMNA
SCHEMBL3932407 0.79 ALDH1A1 (0.49) THRBALDH1A1NPSR1TSHRLMNA
SCHEMBL3750006 0.78 ALDH1A1 (0.66) THRBALDH1A1NPSR1TSHRLMNA
SCHEMBL14790130 0.78 ALDH1A1 (0.53) ALDH1A1TSHRLMNASMN1; SMN2MAPT
SCHEMBL3930561 0.77 TP53 (0.54) THRBALDH1A1NPSR1TSHRLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090291983-A1 3-Oxoisoindoline-1-Carboxamide Derivatives as Analgesic Agents ASTRAZENECA AB (SE) 2009-11-26 US disclosed
EP-2044019-A1 3-OXOISOINDOLINE-1-CARBOXAMIDE DERIVATIVES AS ANALGESIC AGENTS Astra Zeneca AB (SE) 2009-04-08 EP disclosed
WO-2008008020-A1 3-OXOISOINDOLINE-1-CARBOXAMIDE DERIVATIVES AS ANALGESIC AGENTS ASTRAZENECA AB (SE) 2008-01-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090291983-A1 3-Oxoisoindoline-1-Carboxamide Derivatives as Analgesic Agents OPRD1, OPRK1, OPRM1 THRB 2134/4885ALDH1A1 429/4885NPSR1 66/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.